Richard Chang, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Targeted Therapy
Albert Einstein College of Medicine of Yeshiva University
Medical School
University of Southern California - LAC+USC Medical Center
Residency
NYU School of Medicine
Fellowship
American Board of Internal Medicine
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
OH State Medical License Active through 2019
NY State Medical License Active through 2013
Treatment of high-risk venous thrombosis patients using low-dose intraclot injections of recombinant tissue plasminogen activator and regional anticoagulation.
Chang, R.,Butman, J. A.,Lonser, R. R.,Sherry, R. M.,Pandalai, P. K.,Horne, M. K.,Lozier, J. N.; J Vasc Interv Radiol. 2013 Jan.
See more >>Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
ohen, D.J., Newman, E., Iqbal, S., Chang, R.Y., Potmesil, M., Ryan, T., Donahue, B., Chandra, A., Liu, M., Utate, M., Hiotis, S., Pachter, L.H., Hochster, H., Muggia, F.; Ann Surg Oncol. 2012 Feb.
See more >>Role of family history and ethnicity on the mode and age of prostate cancer presentation.
Cotter, M.P., Gern, R.W., Ho, G.F., Chang, R.Y., Burk, R.D.; Prostate. 2002 Mar 1.
See more >>